Eagle Bay Advisors’s Zai Lab ZLAB Stock Holding History

Eagle Bay Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9	Closed	-$1K	–	1000
2021 Q4	$1K	Sell	9 -9	-50%	-$763	﹤0.01%	1073
2021 Q3	$2K	Buy	+18	New	+$2.58K	﹤0.01%	1007

Other funds holding ZLAB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Eagle Bay Advisors's ZLAB Position: Q1 2022 in Review

Eagle Bay Advisors sold out of Zai Lab (ZLAB) in Q1 2022, closing a stake of 9 shares — an estimated $1K sold.

Eagle Bay Advisors first reported a position in ZLAB in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 175 funds tracked by Wall St. Rank hold ZLAB as of Q1 2022.

Eagle Bay Advisors reported no remaining Zai Lab position as of Q1 2022 after selling out during the quarter.
Eagle Bay Advisors sold 9 Zai Lab shares in Q1 2022, an estimated $1K.
Eagle Bay Advisors first reported a position in Zai Lab in Q3 2021 and held it in 2 quarters.
Eagle Bay Advisors's Zai Lab position peaked at $2K in Q3 2021.
175 funds tracked by Wall St. Rank held Zai Lab as of Q1 2022.

Based on Eagle Bay Advisors's 13F filing for Q1 2022, filed 11 May 2022.